Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Evolution of the thrombolytic treatment window for acute ischemic stroke.

Stemer A, Lyden P.

Curr Neurol Neurosci Rep. 2010 Jan;10(1):29-33. doi: 10.1007/s11910-009-0076-8. Review.

3.

Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.

García-Bermejo P, Calleja AI, Pérez-Fernández S, Cortijo E, del Monte JM, García-Porrero M, Fe Muñoz M, Fernández-Herranz R, Arenillas JF.

Cerebrovasc Dis. 2012;34(1):31-7. doi: 10.1159/000338778. Epub 2012 Jun 29.

PMID:
22759450
4.

[Prospects of thrombolytic therapy for acute ischemic stroke].

Nakashima T, Minematsu K.

Brain Nerve. 2009 Sep;61(9):1003-12. Review. Japanese.

PMID:
19803399
5.

A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.

Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB; ARTIS study group.

Trials. 2010 May 12;11:51. doi: 10.1186/1745-6215-11-51.

6.

MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.

Li YH, Li MH, Zhao JG, Wang W.

J Neuroimaging. 2011 Oct;21(4):332-9. doi: 10.1111/j.1552-6569.2010.00544.x. Epub 2010 Dec 1.

PMID:
21121996
7.

[Pharmacotherapy of stroke].

Bereczki D.

Neuropsychopharmacol Hung. 2009 Mar;11(1):7-13. Review. Hungarian.

8.

Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).

Eissa A, Krass I, Bajorek BV.

J Clin Pharm Ther. 2012 Dec;37(6):620-9. doi: 10.1111/j.1365-2710.2012.01366.x. Epub 2012 Jun 19. Review.

PMID:
22708668
9.

Thrombolysis for acute ischemic stroke.

Uyttenboogaart M, De Keyser J, Luijckx GJ.

Curr Top Med Chem. 2009;9(14):1285-90. Review.

PMID:
19849662
10.

Current acute stroke trials and their potential impact on the therapeutic time window.

Schellinger PD, Köhrmann M.

Expert Rev Neurother. 2012 Feb;12(2):169-77. doi: 10.1586/ern.11.198.

PMID:
22288672
11.

Thrombolytic therapy for acute ischemic stroke.

Blakeley JO, Llinas RH.

J Neurol Sci. 2007 Oct 15;261(1-2):55-62. Epub 2007 Jul 5. Review.

PMID:
17618652
12.

SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.

Ciccone A, Valvassori L, Nichelatti M; SYNTHESIS Expansion investigators.

Int J Stroke. 2011 Jun;6(3):259-65. doi: 10.1111/j.1747-4949.2011.00587.x. Epub 2011 Mar 18.

PMID:
21557814
13.

[Thrombolysis and acute cerebral infarction].

Abboud H, Amarenco P.

Med Sci (Paris). 2004 Dec;20(12):1104-8. Review. French.

14.
15.

The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.

Kahn JH, Viereck J, Kase C, Jeerakathil T, Romero R, Mehta SD, Kociol R, Babikian V.

J Emerg Med. 2005 Oct;29(3):273-7.

PMID:
16183445
16.

Plasminogen activation and thrombolysis for ischemic stroke.

Medcalf RL, Davis SM.

Int J Stroke. 2012 Jul;7(5):419-25. doi: 10.1111/j.1747-4949.2012.00783.x. Epub 2012 Mar 30. Review.

PMID:
22463085
17.

Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel.

Xu AD, Wang YJ, Wang DZ; Chinese Stroke Therapy Expert Panel for Intravenous Recombinant Tissue Plasminogen Activator.

CNS Neurosci Ther. 2013 Aug;19(8):543-8. doi: 10.1111/cns.12126. Epub 2013 May 27.

PMID:
23710819
18.

Alteplase for acute ischemic stroke.

Gonzales NR, Grotta JC.

Expert Rev Cardiovasc Ther. 2006 May;4(3):301-18. Review.

PMID:
16716092
19.

Intravenous thrombolysis for acute ischemic stroke--our experiences.

Antoncić I, Dunatov S, Bralić M, Perković O, Coklo M, Jurjević A.

Coll Antropol. 2011 Jun;35(2):483-6.

PMID:
21755722
20.

Efficacy and safety of i.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset.

Otwell JL, Phillippe HM, Dixon KS.

Am J Health Syst Pharm. 2010 Jul 1;67(13):1070-4. doi: 10.2146/ajhp090501. Review.

PMID:
20554592

Supplemental Content

Support Center